Tradestie Institutional Equity Comparison Engine

ZJYL vs EKSO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZJYL Overall Edge

ZJYL Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) driven by superior Valuation, Growth & Margin while EKSO counters with relative strength in Momentum & Technical. Fundamentally, ZJYL trades at N/M Forward P/E with 2.1% operating margin (-9.7% YoY revenue) versus EKSO at N/M Forward P/E and -119.7% operating margin (-38.3% YoY). In options structure, ZJYL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ZJYL
ZJYL N/M vs EKSO N/M Fwd P/E
Growth & Margin Winner ZJYL
Op Margin 2.1% vs -119.7% ยท YoY -9.7% vs -38.3%
Momentum & Technical Winner EKSO
1Y +1151.8% vs +62.6% ยท 52W Pos 68% vs 87%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZJYL NASDAQ
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$3.38
+1.2% 1D
Market Cap $531.7M
1M Return +67.33%
1Y Return +1151.85%
Forward P/E N/M
Unified AI Score
40.7 / 100 SELL
Tech 22.0 Fund 38.0 Flow 50.0 Mom 50.0
EKSO NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap $42.0M
1M Return +25.53%
1Y Return +62.6%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZJYL +1151.85% EKSO +62.6% Spread: +643.26 pp (ZJYL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZJYL TTM Op. Margin: 2.1% EKSO TTM Op. Margin: -119.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZJYL vs EKSO. Trailing 12-month operating profitability (ZJYL 2.1% vs EKSO -119.7%) and valuation multiples (ZJYL N/M vs EKSO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZJYL (6) vs EKSO (3)
Institutional Metric ZJYL EKSO Criterion Row Winner
Market Capitalization Scale $531.7M $42.0M Larger Scale ZJYL
Trailing P/E Ratio Valuation 17.6x N/M Lower Multiple ZJYL
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -9.7% -38.3% Higher Growth ZJYL
Operating Margin (TTM) Profitability 2.1% -119.7% Higher Margin ZJYL
Net Profit Margin Profitability 5.9% -91.4% Higher Margin ZJYL
Return on Equity (ROE) Capital Efficiency 4.0% -107.6% Higher ROE ZJYL
52-Week Range Position Momentum 68% ($0โ€“$5) 87% ($0โ€“$14) Stronger Trend EKSO
Beta / 30D Volatility Risk Regime 0.72ฮฒ ยท 177% Vol 2.16ฮฒ ยท 76% Vol Lower Realized Risk EKSO
Unified Institutional Score Composite Signal 40.7 / 100 (SELL) 58.1 / 100 (HOLD) Higher Composite EKSO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZJYL vs EKSO Buy Guide
ZJYL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZJYL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EKSO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EKSO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZJYL nor EKSO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.